← Back to Genomic Valley Biotech Ltd Overview
📊Financials📈PE Ratio🥧Shareholding💰Dividend📋Quarterly⚖️Balance Sheet💹P&L🌊Cash Flow
GVBLBiotechnology

Genomic Valley Biotech Ltd — Financial Ratios & Key Metrics

₹28.00
+3.74%
P/E Ratio88.14xIndustry: 51.82x
ROE9.68%Return on equity
ROCE11.83%Return on capital
Debt/Equity0.00Debt free ✓
💎

Valuation & Profitability

P/E Ratio
88.14x
Industry Average P/E
51.82x
Dividend Yield
0.00%
Market Cap
₹8.81 (Cr)
Sales Growth 5Y
-0.24%
Profit Growth 5Y
4.42%
EPS Growth 5Y
4.42%
OPM 5Y Avg
20.70%
📉

Price Returns

1 Month
-5.13%
3 Months
-30.96%
6 Months
-37.64%
1 Year
-72.03%
52W Low
₹20
Current
₹28
52W High
₹64
18% of 52-week range — Near lows
🔬

Technical Indicators

45RSI 14
Neutral
Momentum is balanced — neither overbought nor oversold.
SMA 50
₹26
▲ Price above SMA 50 — Bullish
SMA 200
₹35
▼ Long-term downtrend
Volume Signal
348% of avg
Above average volume — strong conviction behind price move

Technical indicators are for educational purposes only. Not investment advice.

More on Genomic Valley Biotech Ltd

OverviewFinancialsPE HistoryShareholdingQuarterlyBalance SheetP&LCash FlowBiotechnology StocksScreener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.